Volodymyr Dariy

Volodymyr Dariy

Auto-generated profile, based on publicly available information

Volodymyr Dariy

Zaporizhzhia State Medical and Pharmaceutical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2022 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
VCV. V. Chuhunov
V. V. Chuhunov
VDV. I. Darii
V. I. Darii
DSD. M. Safonov
D. M. Safonov
AHA. D. Horodokin
A. D. Horodokin
Aim. To systematize neuroleptic-induced and neurologic components of residual condition in schizophrenia. Materials and methods. 100 patients of Communal Non-Profit Enterprise “Regional Clinical Institution for the Provision of Psychiatric Care” of Zaporizhzhia Regional Council with diagnosis of recurrent schizophrenia (ICD-10: F20.5) were examined. Results. The study has found correlations between pharmacotherapy and cerebrovascular pathology with positive and negative symptoms of residual schizophrenia. Noticeable positive correlations were established between specific antipsychotic prescriptions and positive negative schizophrenia symptoms, while only minor correlations with negative symptoms were found. Analysis of cerebrovascular pathology with positive and negative symptoms showed that most noticeable positive correlations were anterior area stroke with hallucinations. Overall dominance of negative correlations over positive ones showed possible trend of “forced normalization” caused by cerebrovascular pathology of schizophrenia manifestations in recurrent condition, which was, however, also minor. Conclusions. The study has found correlations between pharmacotherapy and cerebrovascular pathology with positive and negative symptoms of residual schizophrenia. The concept of “antipsychotic course experience” was introduced.

30 September 2024 in PAIN, JOINTS, SPINE
Verified
Journal Article
Open access
PDF file
TAT.O. Andreeva
T.O. Andreeva
OSO.M. Stoyanov
O.M. Stoyanov
EME.M. Mirdjuraev
E.M. Mirdjuraev
GCG.M. Chebotareva
G.M. Chebotareva
VKV.I. Kalashnikov
V.I. Kalashnikov
VDV.I. Dariy
V.I. Dariy
Background. The neck, its bone-cartilaginous and muscle apparatus, etc. high activity is well known. Cervical spine degenerative-dystrophic processes are considered to be an urgent problem. The purpose of the study was to determine the clinical and morphometric changes of the cervical spine in humans and animals with neck pain based on a clinical and neurological examination, determination of the vertebral body density, their configuration, and ratio for timely correction and prognosis of this patho­logy. Materials and methods. Pain intensity was studied in humans and animals using the adapted visual-analogue scale. The inde­xes of computer tomography with measurement of vertebral body density, and morphometric indexes with an emphasis on C5-C7 le­vel were also studied. All studies were conducted following existing bioethical standards. Results. The pathology of spine configuration was registered in 84.6 % of the examined patients in the form of angular kyphosis or straightened lordosis, more often in women. It was observed in 34.7 % of cases in dogs and cats. The normal configuration is more common: in cats — 78.6 % and in dogs of small breeds — 78.5 %, in large breed dogs — only 26.3 %, and deformations were more frequent than in cats and small dogs (2.7 times more). The cervical vertebrae bodies density in all groups decreased toward the caudal direction with a difference of 18.1 % in humans. In cats — 2.7 %, in dogs of small breeds, it was higher (7.5 %), and in large breed dogs, it reached 14.3 %. The maximum deviations of the studied indicators were found in humans and maximally coincided with those in dogs of large breeds. Conclusions. Thus, animals, especially dogs of large breeds, can serve as a model for studying etiopathogenetic factors, the course, prognosis of degeneration of the bone-cartilage apparatus.

1 June 2020 in Problems of Uninterrupted Medical Training and Science
Verified
Journal Article
Closed access
VDV. I. Dariy
V. I. Dariy
ZUZaporizhzhia State Medical University
Zaporizhzhia State Medical University
OSO. M. Stoyanov
O. M. Stoyanov
IVI. V. Vizir
I. V. Vizir
MSM. V. Sikorskaya
M. V. Sikorskaya
Z2Zaporizhia City Clinical Hospital No. 2
Zaporizhia City Clinical Hospital No. 2
PUMTS. 2020; 38(2): 47-52. https://doi.org/10.31071/promedosvity2020.02.047 Brain stroke (BS) is the number one problem

8 November 2024 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
IBI. M. Bilai
I. M. Bilai
VDV. I. Dariy
V. I. Dariy
AKA. V. Khilkovets
A. V. Khilkovets
ABA. I. Bilai
A. I. Bilai
IDI. F. Duiun
I. F. Duiun
The activation of lipid free radical oxidation is a key stage in the development of many diseases and can lead to the emergence of related complications. To identify new synthetic compounds with antioxidant properties, it is necessary to conduct studies on various models of experimental free radical oxidation of biomolecules. Literature sources indicate that among the derivatives of 1,2,4-triazole, there is a significant number that possess high antioxidant activity. The aim of the study to assess the antioxidant properties of newly synthesized S-derivatives of 1,2,4-triazole through the inhibition of reactive oxygen species accumulation in the superoxide dismutase system. Materials and methods. To achieve this goal, we used one of the methods for assessing antioxidant activity by initiating free radical processes in vitro, specifically by inhibiting the accumulation of reactive oxygen species. Results. Twenty-three S-derivatives of 5-(thiophene-3-ylmethyl)-4-R-1,2,4-triazole-3-thiols were investigated. The most effective compound was sodium 2-((4-phenyl-5-thiophene-3-ylmethyl)-1,2,4-triazole-3-yl)thio)acetate, which exceeded the activity of both reference drugs. Following in activity was compound 22, 1-phenyl-2-((4-phenyl-5-(thiophene-3-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)ethanol, which demonstrated an effect similar to that of emoxipine, while compound 7, 1-(3-fluorophenyl)-2-((5-thiophene-3-ylmethyl)-4H-1,2,4-triazole-3-yl)thio)ethanone, was slightly less active. Conclusions. It was established that among the new S-derivatives of 1,2,4-triazole, some exhibit significant antioxidant effects that are comparable to or exceed the efficacy of reference drugs.

1 April 2019
Verified
Journal Article
Closed access
VDVolodymyr Dariy
Volodymyr Dariy
TMT Mishchenko
T Mishchenko
KSK Serikov
K Serikov

30 September 2022 in Medical Science of Ukraine (MSU)
Verified
Journal Article
Open access
PDF file
ОSО.м. Stoyanov
О.м. Stoyanov
RVR.S. Vastyanov
R.S. Vastyanov
ASA.S. Son
A.S. Son
VKV.Y. Kalashnikov
V.Y. Kalashnikov
ОHО.а. Hruzevskyi
О.а. Hruzevskyi
SOS.M. Oliinyk
S.M. Oliinyk
Relevance. Mnestic functions in patients after stroke and coronavirus infection are not restored completely. Nowadays, the search for ways to overcome in such patients is actual. Objective: to find out the possibility of cognitive deficiency’ overcoming in persons after stroke who have suffered from COVID-19 by Phenibut pharmacocorrection and magnetic therapy. Materials and methods. 46 patients aged 40-60 years who had COVID-19 in anamnesis and ischemic stroke in the post-covid period were divided into 3 groups at the stage of comprehensive rehabilitation. In the 1st group (n=15) - the control group - no nootropic drugs and physiotherapeutic procedures were not asdministered; in group 2 (n=15), magnet stimulation procedures were performed for 20 days (frequency of basic impulses 180-195 Hz, frequency of a group of impulses 12,5-29 Hz, average induction of magnetic fields within 100 μT); group 3 (n=16) took Phenibut (β-Phenyl-GABA) one tablet (250 mg) 3 times a day for three months. The study of cognitive functions was carried out with the help of a short mental state scale - MMSE, a set of tests for the study of frontal dysfunction - FAB, a test for memorizing of 10 words according to the A.R. Luria’s method and clock drawing testing All groups were tested twice: at the beginning of the study and after three months. The obtained data were processed statistically; an ordinal logistic regression model was applied, in particular logistic regression with a cumulative relationship. The results. In group 2 the result of the subtest "Voluntary attention" improved (3,8±0,3 points vs. 3,1±0,2 in the control) and the FAB test (15, 2±1,2 points vs. 11,3±0,4 in control). In group 3, the cognitive functions in the MMSE (26,1±0,8 points vs. 21,2±0,6 in the control) and FAB (16,3±0,6 points vs. 11,3±0,4) tests probably improved. The results of the subtests "Discretionary attention" (3,8±0,1 points vs. 3,1±0,1) and "Memory" (2,6±0,2 points vs. 2,0±0,1) improved. In the test for 10 words memorizing, the difference in indicators, compared to the control, was in each subsequent presentation: 1,0±0,05; 1,1±0,09; 1,7±0,10 words, in delayed presentation 1,75±0,05 (in all cases p<0.05). Conclusions. The use of Phenibut and magnetic therapy in patients who have suffered a stroke after COVID-19 leads to regression of cognitive deficiency and depressive symptoms. The effect of Phenibut turned out to be better - the odds ratio, compared to the control, was 13,1.